Your browser doesn't support javascript.
loading
Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance.
Maity, Tapan K; Kim, Eun Young; Cultraro, Constance M; Venugopalan, Abhilash; Khare, Leena; Poddutoori, Ramulu; Marappan, Sivapriya; Syed, Samiulla D; Telford, William G; Samajdar, Susanta; Ramachandra, Murali; Guha, Udayan.
  • Maity TK; Thoracic and GI Malignancies Branch, CCR, NCI, NIH, Bethesda, MD 20892, USA.
  • Kim EY; Thoracic and GI Malignancies Branch, CCR, NCI, NIH, Bethesda, MD 20892, USA.
  • Cultraro CM; Thoracic and GI Malignancies Branch, CCR, NCI, NIH, Bethesda, MD 20892, USA.
  • Venugopalan A; Thoracic and GI Malignancies Branch, CCR, NCI, NIH, Bethesda, MD 20892, USA.
  • Khare L; Aurigene Discovery Technologies Ltd., Bangalore 560100, India.
  • Poddutoori R; Aurigene Discovery Technologies Ltd., Bangalore 560100, India.
  • Marappan S; Aurigene Discovery Technologies Ltd., Bangalore 560100, India.
  • Syed SD; Aurigene Discovery Technologies Ltd., Bangalore 560100, India.
  • Telford WG; Experimental Transplantation & Immunotherapy Branch, CCR, NCI, NIH, Bethesda, MD 20892, USA.
  • Samajdar S; Aurigene Discovery Technologies Ltd., Bangalore 560100, India.
  • Ramachandra M; Aurigene Discovery Technologies Ltd., Bangalore 560100, India.
  • Guha U; Thoracic and GI Malignancies Branch, CCR, NCI, NIH, Bethesda, MD 20892, USA.
Cancers (Basel) ; 15(8)2023 Apr 12.
Article en En | MEDLINE | ID: mdl-37190191

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article